Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership
Collaboration to develop novel, next-generation therapeutics to treat heart disease Osaka, Japan and Cambridge, Mass., – 2 August 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502) and [...]
